Search for Clinical Trial Results

Sponsored By

Hemolysis - 25 Studies Found

Status Study
Recruiting Study Name: Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty
Condition: Hemolysis
Date: 2008-11-17
Interventions: Drug: Propofol Patients in the Propofol Group (PG) will be induced with target-controlled infusion (TCI)
Completed Study Name: Investigating the Influence of Haemolysis on the Potassium Concentration After Capillary Blood Sampling
Condition: Hemolysis
Date: 2015-11-24
Interventions:
  • Other: capillary blood sampling

Recruiting Study Name: Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department.
Condition:
  • Hemolysis
  • Blood Specimen Collection

Date: 2016-11-24
Interventions: Device: Hemolysis Point-of-Care test Hemolysis measurement of plasma using a point of care test to deter
Completed Study Name: Isoagglutinins in the Development of IVIG-associated Hemolysis
Condition:
  • Immunoglobulins, Intravenous
  • Hemolysis

Date: 2014-08-29
Completed Study Name: Hemolysis in Patients With Hereditary Spherocytosis (HS)
Condition:
  • Hereditary
  • Hemolysis

Date: 2010-09-12
Interventions: Other: fermented papaya preparation (FPP) Hemolysis will be assayed by suspending 3 ml of packed RBC in
Not yet recruiting Study Name: Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease
Condition: Haemolysis Neonatal
Date: 2017-04-24
Interventions: Drug: intravenous immunoglobulin giving intravenous immunoglobulin to neonates included in inclusion cri
Completed Study Name: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Date: 2010-08-31
Interventions: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following
Completed Study Name: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Date: 2010-08-31
Interventions: Drug: Eculizumab Fixed dosing is based on body weight cohorts. Adjustment of dose to accommodate patient
Recruiting Study Name: A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Condition: Warm Antibody Autoimmune Hemolytic Anemia
Date: 2015-11-19
Interventions: Drug: Fostamatinib 150 mg bid Fostamatinib 150 mg bid. The dose of Fostamatinib may be reduced at any ti
Recruiting Study Name: R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions
Condition: Hemolysis
Date: 2012-03-16
Next >>>